Reasons underlying the intention to vaccinate children aged 5-11 against COVID-19: A cross-sectional study of parents in Israel, November 2021.

COVID-19 Covid-19 and children childhood vaccines parental vaccine hesitancy vaccine hesitancy

Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
30 Nov 2022
Historique:
pubmed: 30 8 2022
medline: 15 12 2022
entrez: 29 8 2022
Statut: ppublish

Résumé

Vaccination is a key tool to mitigate impacts of the COVID-19 pandemic. In Israel, COVID-19 vaccines became available to adults in December 2020 and to 5-11-year-old children in November 2021. Ahead of the vaccine roll-out in children, we aimed to determine whether surveyed parents intended to vaccinate their children and describe reasons for their intentions. We collected information on parental socio-demographic characteristics, COVID-19 vaccine history, intention to vaccinate their children against COVID-19, and reasons for parental decisions using an anonymous online survey. We identified associations between parental characteristics and plans to vaccinate children using a logistic regression model and described reasons for intentions to vaccinate or not. Parental non-vaccination and having experienced major vaccination side effects were strongly associated with non-intention to vaccinate their children (OR 0.09 and 0.18 respectively, Parental intention to vaccinate children aged 5-11 is much lower than vaccine coverage in parental age groupsBeing unvaccinated and having experienced side effects following vaccination were the greatest negative predictors in parents of intention to vaccinate their childrenParents were more likely to accept a COVID-19 vaccine for their children to allow them to return to daily social life and to ensure economic security in the familyParents were more likely to reject a COVID-19 vaccination for health reasons such as safety concerns or due the belief that COVID-19 was a mild disease in children.

Autres résumés

Type: plain-language-summary (eng)
Parental intention to vaccinate children aged 5-11 is much lower than vaccine coverage in parental age groupsBeing unvaccinated and having experienced side effects following vaccination were the greatest negative predictors in parents of intention to vaccinate their childrenParents were more likely to accept a COVID-19 vaccine for their children to allow them to return to daily social life and to ensure economic security in the familyParents were more likely to reject a COVID-19 vaccination for health reasons such as safety concerns or due the belief that COVID-19 was a mild disease in children.

Identifiants

pubmed: 36037533
doi: 10.1080/21645515.2022.2112879
pmc: PMC9746408
doi:

Substances chimiques

COVID-19 Vaccines 0
Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2112879

Références

Emerg Infect Dis. 2019 Oct;25(10):1834-1842
pubmed: 31538559
Vaccines (Basel). 2021 Mar 22;9(3):
pubmed: 33810131
Vaccine. 2021 Apr 8;39(15):2024-2034
pubmed: 33722411
Med Microbiol Immunol. 2016 Jun;205(3):201-8
pubmed: 26935826
J Clin Rheumatol. 2020 Sep;26(6):220-223
pubmed: 32852927
Bull World Health Organ. 2009 Aug;87(8):624-30
pubmed: 19705014
Vaccines (Basel). 2021 Sep 30;9(10):
pubmed: 34696223
Vaccine. 2022 Mar 18;40(13):2053-2061
pubmed: 35168839
J Health Commun. 2020 Oct 2;25(10):831-837
pubmed: 33719886
Lancet Infect Dis. 2020 Aug;20(8):875
pubmed: 32687807
EBioMedicine. 2016 Oct;12:295-301
pubmed: 27658738
MMWR Morb Mortal Wkly Rep. 2021 Nov 12;70(45):1579-1583
pubmed: 34758012
Syst Rev. 2022 Apr 26;11(1):78
pubmed: 35473819
J Pediatr Health Care. 2021 Sep-Oct;35(5):509-517
pubmed: 34217553
PLoS One. 2021 Dec 17;16(12):e0261121
pubmed: 34919580
BMC Public Health. 2021 Sep 13;21(1):1662
pubmed: 34517848
Euro Surveill. 2019 Feb;24(6):
pubmed: 30755293
Vaccine. 2021 Dec 3;39(49):7140-7145
pubmed: 34763947
Pediatrics. 2016 Sep;138(3):
pubmed: 27573088
Vaccines (Basel). 2021 Aug 19;9(8):
pubmed: 34452052
N Engl J Med. 2022 Jan 6;386(1):35-46
pubmed: 34752019
Lancet Reg Health Eur. 2022 Jan;12:100234
pubmed: 34746908
Int J Environ Res Public Health. 2021 Sep 28;18(19):
pubmed: 34639527
Vaccine. 2020 Nov 17;38(49):7789-7798
pubmed: 33109389
PLoS One. 2017 Jan 26;12(1):e0170550
pubmed: 28125629
Vaccine. 2021 Dec 20;39(52):7669-7676
pubmed: 34688500

Auteurs

Nicole G Morozov (NG)

Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Amiel A Dror (AA)

Galilee Medical Center, Nahariyah, Israel.
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Amani Daoud (A)

Galilee Medical Center, Nahariyah, Israel.
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Netanel Eisenbach (N)

Galilee Medical Center, Nahariyah, Israel.
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Edward Kaykov (E)

Galilee Medical Center, Nahariyah, Israel.
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Masad Barhoum (M)

Galilee Medical Center, Nahariyah, Israel.
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Tsvi Sheleg (T)

Galilee Medical Center, Nahariyah, Israel.
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Eyal Sela (E)

Galilee Medical Center, Nahariyah, Israel.
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Michael Edelstein (M)

Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH